Sam L. Barker, Director at CADENCE PHARMACEUTICALS INC (CADX), bought 9,000 shares at $7.04 ($63K) on 2011-05-10, disclosed to the SEC on 2011-05-11.
Open-market purchase of $63k CADX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| LXRX | BUY | 2019-08-02 | $28K | — | Filing → |
| LXRX | BUY | 2017-09-18 | $13K | — | Filing → |
| CYCC | BUY | 2014-11-20 | $9K | — | Filing → |